Search Results 1011-1020 of 13327 for monoclonal antibody
... monoclonal anti-CD20 antibody, for patients with relapsed or refractory B Cell non-Hodgkin lymphoma (NHL). A Phase 1 AAV Gene Therapy Trial Evaluating ...
Our chronic migraine treatment uses VYEPTI infusions, delivered intravenously. VYEPTI is a monoclonal antibody that targets calcitonin gene-related peptide ( ...
... monoclonal antibody (i.e., daratumumab). Subject has Measurable Disease, defined as at least 1 of the following: Serum M-protein ≥ 0.5 g/dL (≥ 5 g/L);.
Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 · 2021 Gerstner Awardees to investigate individualized ...
A Study of the Safety and Effectiveness of Eculizumab to Prevent Antibody-Mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation.
About this study. Given that family members of CLL patients are known to have an increased risk of CLL (on the order of 8-fold), and they have a higher ...
The purpose of this study is to determine the efficacy of pembrolizumab in patients with advanced sarcomas. Participation eligibility. Participant eligibility ...
... monoclonal antibody reversed the therapeutic effect of IVIG. Protection was associated with the ability of IVIG administration to induce surface expression ...
These are the findings of a study by Mayo Clinic researchers published in the Wednesday, Jan. 17, issue of the New England Journal of Medicine. Monoclonal ...
Researchers also tested monoclonal antibodies to block or neutralize the IL-4 protein. They found that it also rejuvenated CAR-T cells and their ability to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.